Powell MA, Cibula D, O'Malley DM, Boere I, et al. Efficacy and safety of dostarlimab in combination with chemotherapy in patients
with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3,
randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY). Gynecol Oncol 2024;192:40-49.
PMID: 39531903
|